Homeostasis Model Assessment (HOMA-IR) was used to predict insulin resistance.Results: In the PCOS group, menstrual cycle duration and FG scores were significantly higher (P-value,
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Aim: : To measure obestatin levels in the blood and saliva samples of normal-weight patients with polycystic ovary syndrome(PCOS) in comparison with normal-weight healthy controls, and to determine whether there were relationships between blood and/or salivary obestatin levels and other measured parameters.Materials and Methods: Fifteen healthy women and 15 patients with PCOS, all of which had normal weight, were included in thestudy.
📊
Key Findings & Data:Participants’ age, height, weight, menstrual characteristics, hormone levels, body mass index, waist/hip ratio, and modified Ferriman-Gallwey (FG) scores were recorded.
💡
Conclusion & Impact:Homeostasis Model Assessment (HOMA-IR) was used to predict insulin resistance.Results: In the PCOS group, menstrual cycle duration and FG scores were significantly higher (P-value,
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Aim: : To measure obestatin levels in the blood and saliva samples of normal-weight patients with polycystic ovary syndrome(PCOS) in comparison with normal-weight healthy controls, and to determine whether there were relationships between blood and/or salivary obestatin levels and other measured parameters.Materials and Methods: Fifteen healthy women and 15 patients with PCOS, all of which had normal weight, were included in thestudy. Participants’ age, height, weight, menstrual characteristics, hormone levels, body mass index, waist/hip ratio, and modified Ferriman-Gallwey (FG) scores were recorded. Obestatin levels were measured in both fasting blood and saliva samples. Homeostasis Model Assessment (HOMA-IR) was used to predict insulin resistance.Results: In the PCOS group, menstrual cycle duration and FG scores were significantly higher (P-value,
🔖
Cite This Article
Yavuz, A., Aydin, S., Gurates, B. (2022). Serum and salivary obestatin concentrations in thediagnosis of polycystic ovary syndrome. Annals of Medical Research, Cilt: 28 - Sayı: 5, 1024–1028. https://ajindex.com/articles/445761
Bozdag G, Mumusoglu S, Zengin D, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta- analysis. Hum Reprod 2016;31:2841-55
Group REASPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human reproduction 2004;19:41-7
Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev 2016;37:467-520
Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005;310:996-9
Tang SQ, Jiang QY, Zhang YL, et al. Obestatin: its physicochemical characteristics and physiological functions. Peptides 2008;29:639-45
Granata R, Settanni F, Gallo D, et al. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes 2008;57:967-79
Pradhan G, Wu C-S, Lee JH, et al. Obestatin stimulates glucose-induced insulin secretion through ghrelin receptor GHS-R. Sci Rep 2017;7:979
Romani F, Lanzone A, Tropea A, et al. In vitro effect of unacylated ghrelin and obestatin on human luteal cell function. Fertil Steril 2012;97:991-6
Taskin MI, Bulbul E, Adali E, et al. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology 2015;189:19-23
El-Fattah AIA, Elboghdady AA, Kamel MM, et al. Obestatin and Copeptin Levels in Egyptian Polycystic Ovary Patients and their Relation to Obesity, Insulin Resistance and Cardiovascular Risk. Merit Res J Med Med Sci 2016;4:451-7
Rahmani E, Akbarzadeh S, Broomand A, et al. Serum Levels of Angiopoietin-Like Protein 2 and Obestatin in Iranian Women with Polycystic Ovary Syndrome and Normal Body Mass Index. J of Clinical Med 2018;7:159
Wu W, Fan X, Yu Y, et al. Alteration of ghrelin/obestatin ratio in adolescence with polycystic ovarian syndrome. Gynecol Endocrinol 2018;34:36-9
Ozbay Y, Aydin S, Dagli AF, et al. Obestatin is present in saliva: alterations in obestatin and ghrelin levels of saliva and serum in ischemic heart disease. BMB reports 2008